
A wheelchair project, a thesis, two acquired companies and one stubbornly durable question shaped Maria Bennett's route from an Indiana marching band to a Cleveland medtech exit.
Maria Bennett noticed that an experiment built to restore movement was doing something patients valued more: easing pain. SPR spent the next 16 years turning that side effect into a temporary implant, a reimbursement machine, and a $650 million Medtronic acquisition.